Get started
Author

Bradley Stockard

ORCID: 0000-0001-8770-9423
Observed ORCID: 0000-0001-8770-9423
OpenAlex ID: A5045519014
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
2018 · Bradley Stockard, Timothy Garrett, et al. · Scientific Reports · 50
PDF
Cellular Metabolomics Profiles Associated With Drug Chemosensitivity in AML
2021 · Bradley Stockard, Neha Bhise, et al. · Frontiers in Oncology · 21
PDF
Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients
2018 · Sonal Singh, Caitrin W. McDonough, et al. · Journal of the American Heart Association · 18
Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life
2022 · Wojciech Krzyzanski, Bradley Stockard, et al. · CPT Pharmacometrics & Systems Pharmacology · 8
PDF
Metabolomics Profiling Reveals Markers for Chemosensitivity and Clinical Outcomes in Pediatric AML Patients
2018 · Bradley Stockard, Huiyun Wu, et al. · Blood · 7
Pharmacometabolomics Profiling of Preterm Infants Validates Patterns of Metabolism Associated With Response to Dexamethasone Treatment for Bronchopulmonary Dysplasia
2022 · Bradley Stockard, Cheri Gauldin, et al. · Frontiers in Pediatrics · 5
PDF
Metabolomic Profiling Defines Distinct Metabolic Signature Associated with FLT3/ITD AML
2016 · Bradley Stockard, Timothy Garrett, et al. · Blood · 1
Cellular Metabolomic Profiling in AML Cell Lines Is Linked to Differences in in Vitro Cytarabine Chemosensitivity
2016 · Bradley Stockard, Joy D Guingab, et al. · Blood
Works count: 8
Citation count: 110
H-index: 5
I10-index: 3
Year
Topic
Type